Anzeige
Meldung des Tages: 20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.

Becton Dickinson Aktie News

Aktie
WKN:  857675 ISIN:  US0758871091 US-Symbol:  BDX Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
148,20 €
+0,00 €
0,00%
09:12:32 Uhr
Depot/Watchlist
Marktkapitalisierung *
47,80 Mrd. €
Streubesitz
5,15%
KGV
31,83
Dividende
3,34 $
Dividendenrendite
2,15%
Nachhaltigkeits-Score
46 %
Index-Zuordnung
S&P 500
Weiter aufwärts? Long handeln - Jetzt mit Hebel 15,69: MN32Z9
Werbung

Becton Dickinson News

10.02.26 - PR Newswire
Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities
Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities PR Newswire
09.02.26 - PR Newswire
Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses
Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses PR Newswire
09.02.26 - PR Newswire
BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation
BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation PR Newswire
09.02.26 - PR Newswire
Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses
Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses PR Newswire
09.02.26 - PR Newswire
BD Reports First Quarter Fiscal 2026 Financial Results
BD Reports First Quarter Fiscal 2026 Financial Results PR Newswire
29.01.26 - PR Newswire
BD and Envetec Demonstrate Closed-Loop Recycling Solution for Laboratory Plastics in Health Care
BD and Envetec Demonstrate Closed-​Loop Recycling Solution for Laboratory Plastics in Health Care PR Newswire
27.01.26 - PR Newswire
BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $250 Million Repurchase to Date in FY26
BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $250 Million Repurchase to Date in FY26 PR Newswire
27.01.26 - PR Newswire
BD to Announce Financial Results for its First Quarter of Fiscal 2026
BD to Announce Financial Results for its First Quarter of Fiscal 2026 PR Newswire
27.01.26 - PR Newswire
Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business
Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business PR Newswire
27.01.26 - PR Newswire
Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business
Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business PR Newswire
27.01.26 - PR Newswire
BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business
BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business PR Newswire
23.01.26 - PR Newswire
BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation
BD Helps Scientists Advance Immunology and Cancer Research with AI-​Powered Insights and Automation PR Newswire
21.01.26 - PR Newswire
BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market
BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market PR Newswire
15.01.26 - PR Newswire
BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System
BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System PR Newswire
14.01.26 - PR Newswire
BD Names Shawn Bevec as Senior Vice President of Investor Relations
BD Names Shawn Bevec as Senior Vice President of Investor Relations PR Newswire
13.01.26 - PR Newswire
BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs
BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs PR Newswire
12.01.26 - PR Newswire
BD To Host Virtual 2026 Annual Meeting of Shareholders
BD To Host Virtual 2026 Annual Meeting of Shareholders PR Newswire
07.01.26 - PR Newswire
Waters Corporation Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Waters Corporation - WAT
Waters Corporation Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Waters Corporation - WAT PR Newswire
05.01.26 - PR Newswire
BD Marks Milestone with First Phasix™ Hernia Prevention Case in Greece and Over 85% Enrollment in U.S. PREVENT Trial
BD Marks Milestone with First Phasix™ Hernia Prevention Case in Greece and Over 85% Enrollment in U.S. PREVENT Trial PR Newswire
18.12.25 - PR Newswire
BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow Cytometry
BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow Cytometry PR Newswire

Newssuche

Videos

newspaper
12.02.26 +3,59%
Technical Trading: Rohöl Long Chance
Rohöl Long Typ: Turbo Open End WKN: VJ2XZJ Hebel: 9,85 Laufzeit: OpenEnd Einstieg: Market ... Mehr »